Thursday, 16 January 2014

Re-analysis of study of pancreatic effects of incretin therapy: Methodological deficiencies

We find that the data presented in the Butler paper have serious methodological deficiencies that preclude any meaningful conclusions (Diabetes, Obesity and Metabolism)


Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes

Our data suggest that treatment with saxagliptin for 6 weeks normalizes retinal capillary flow and improves central hemodynamics in type-2 diabetes (Cardiovascular Diabetology)

Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes

We found no evidence of lower mortality among patients with diabetes who were overweight or obese at diagnosis, as compared with their normal-weight counterparts, or of an obesity paradox (New England Journal of Medicine)


No comments:

Post a Comment